The implementation of pre-exposure prophylaxis (PrEP) as a new tool for prevention against HIV raised particular ethical concerns regarding the individuals’ and the collective's best interests in France. It was questioned whether the beneficence of taking or prescribing PrEP regarding its high efficacy to protect people from HIV is always more important than the maleficence represented by the risks involved, such as healthy people taking a pill with side effects, the growth of sexually transmitted infections or the potential generalization of risk-taking sexual behaviour. The main objective of this study was to explore patients’ and health professionals’ ethical questioning on PrEP. Sixty-nine qualitative interviews were conducted with 45 users and 24 healthcare professionals. Overall, this study shows that those primarily concerned by PrEP tend to dismiss ethical questions regarding PrEP itself in the name of its efficacy and the empowerment it allows, but they would rather stress the impact PrEP can have on individuals’ sexual behaviour and how it can affect their autonomy if it is prescribed blindly without taking into consideration the specific living context and life history of each PrEP user.
SowiczTJTeitelmanAMColemanCL,et al.Considerations for implementing oral preexposure prophylaxis: a literature review. J Assoc Nurses AIDS Care2014; 25: 496–507.
2.
GrantRMLamaJRAndersonPL, et al.Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med2010; 363: 2587–2599.
3.
MolinaJ-MCharreauISpireB, et al.Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study. Lancet HIV2017; 4: e402–e410.
4.
SiguierMMeraRPialouxG, et al.First year of pre-exposure prophylaxis implementation in France with daily or on-demand tenofovir disoproxil fumarate/emtricitabine. J Antimicrob Chemother2019; 74: 2752–2758.
Conseil national du sida et des hépatites virales, Avis sur la place de la PrEP dans la prévention du VIH en France: changer de paradigme, changer d’échelle, 2021. https://cns.sante.fr/rapports-et-avis/avis-prep-2021/ (accessed 14 June 2021).
JacobsonDLSpiegelmanDKnoxTK,et al.Evolution and predictors of change in total bone mineral density over time in HIV-infected men and women in the nutrition for healthy living study. J Acquir Immune Defic Syndr2008; 49: 298–308.
11.
SugarmanJMayerKH. Ethics and pre-exposure prophylaxis for HIV infection. JAIDS J Acquir Immune Defic Syndr2013; 63: S135–S139.
12.
RowniakSPortilloC. Pre-exposure prophylaxis: an ethical discussion. J Assoc Nurses AIDS Care2013; 24: 6–10.
ParkerSChanPAOldenburgCE, et al.Patient experiences of men who have sex with men using pre-exposure prophylaxis to prevent HIV infection. AIDS Patient Care STDS2015; 29: 639–642.
17.
Carlo HojillaJKoesterKACohenSE, et al.Sexual behavior, risk compensation, and HIV prevention strategies among participants in the San Francisco PrEP demonstration project: a qualitative analysis of counseling notes. AIDS Behav2016; 20: 1461–1469.
18.
CollinsSPMcMahanVMSteklerJD. The impact of HIV pre-exposure prophylaxis (PrEP) use on the sexual health of men who have sex with men: a qualitative study in Seattle, WA. Int J Sex Health2017; 29: 55–68.
19.
FournierVBretonnièreSSpranziM. Empirical research in clinical ethics: the ‘committed researcher’ approach. Bioethics2020; 34: 719–726.
20.
FournierVSpranziMFoureurN,et al.The “commitment model” for clinical ethics consultations: society’s involvement in the solution of individual cases. J Clin Ethics2015; 26: 286–296.
21.
BeauchampTLChildressJF. Principles of Biomedical Ethics. 5th ed. New York, NY: Oxford University Press, 2001.
CavanaghS. Content analysis: concepts, methods and applications: content analysis is a flexible methodology that is particularly useful to nurse researchers, asserts Stephen Cavanagh. Nurse Res1997; 4: 5–16.
24.
RivierezIQuatremereGSpireB,et al.Lessons learned from the experiences of informal PrEP users in France: results from the ANRS-PrEPage study. AIDS Care2018; 30: 48–53.
25.
PhilpotSPrestageGHoltM, et al.Gay and bisexual men’s perceptions of pre-exposure prophylaxis (PrEP) in a context of high accessibility: an Australian qualitative study. AIDS Behav2020; 24: 2369–2380.
26.
VenterFAllaisLRichterM. Exposure ethics: does hiv pre-exposure prophylaxis raise ethical problems for the health care provider and policy maker?Bioethics2014; 28: 269–274.
27.
NöstlingerCReyniersTSmekensT, et al.Drug use, depression and sexual risk behaviour: a syndemic among early pre-exposure prophylaxis (PrEP) adopters in Belgium?AIDS Care2020; 32: 57–64.
28.
DevarajanSSalesJMHuntM,et al.PrEP and sexual well-being: a qualitative study on PrEP, sexuality of MSM, and patient-provider relationships. AIDS Care2020; 32: 386–393.
29.
GombeMMCakourosBENcubeG, et al.Key barriers and enablers associated with uptake and continuation of oral pre-exposure prophylaxis (PrEP) in the public sector in Zimbabwe: qualitative perspectives of general population clients at high risk for HIV. PLoS One2020; 15: e0227632.
30.
CastroDRDelabreRMMolinaJ-M. Give PrEP a chance: moving on from the “risk compensation” concept. J Int AIDS Soc2019; 22: e25351.
31.
CastroDRDelabreRMMorelS,et al.Community engagement in the provision of culturally competent HIV and STI prevention services: lessons from the French experience in the era of PrEP. J Int AIDS Soc2019; 22: e25350.
32.
SpranziMFournierV. L’autonomie en question : pratique éthique et enjeux politiques. Raisons Publiques2011; 15: 203–228.
33.
GrantRMKoesterKA. What people want from sex and preexposure prophylaxis. Curr Opin HIV AIDS2016; 11: 3–9.
34.
CiaccioMDProtiereCCastroDR, et al.The ANRS-ipergay trial, an opportunity to use qualitative research to understand the perception of the “participant”-physician relationship. AIDS Care2018; 30: 41–47.
35.
GiamiA. La médicalisation de la sexualité : fausses questions et vrais enjeux. Sexologies2009; 18: 262–264.
36.
DubovAGalboPAlticeFL,et al.Stigma and shame experiences by MSM who take PrEP for HIV prevention: a qualitative study. Am J Mens Health2018; 12: 1843–1854.
37.
MolinaJ-MCapitantCSpireB, et al.On-demand preexposure prophylaxis in men at high risk for HIV-1 infection. N Engl J Med2015; 373: 2237–2246.
PuppoCSpireBMorelS, et al.How PrEP users constitute a community in the MSM population through their specific experience and management of stigmatization. The example of the French ANRS-PREVENIR study. AIDS Care2020; 32: 32–39.
40.
MontessM. Contextualizing risk in the ethics of PrEP as HIV prevention: the lived experiences of MSM. Kennedy Inst Ethics J2021; 31: 343–372.
41.
BrissonJRavitskvVWilliams-JonesB. Towards an integration of PrEP into a safe sex ethics framework for men who have sex with men. Public Health Ethics2018; 12: 54–63.
42.
Beima-SofieKMBrown TrinidasSNgureK, et al.Lessons from PrEP: a qualitative study investigating how clinical and policy experts weigh ethics and evidence when evaluating preventive medications for use in pregnant and breastfeeding women. AIDS Behav2019; 23: 1858–1870.
